Abstract Introduction Low sexual desire is a commonly reported and often distressing form of dysfunction in women. Characterized by diminished interest sex, disinclination to initiate loss pleasure during disorders among women are not only poorly understood from psychological perspective, but also terms their underlying neurobiology. The drug bremelanotide, trade name Vyleesi, was approved the ...